AKT1 and neurocognition in schizophrenia

References

• Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001; 65: 391–426
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005; 122: 261–273
   PubMed Web of Science ®Google Scholar
• Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36(2)131–137
   PubMed Web of Science ®Google Scholar
• Ikeda M, Iwata N, Suzuki T, et al. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry 2004; 56: 698–700
   PubMed Web of Science ®Google Scholar
• Ohtsuki T, Inada T, Arinami T. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol Psychiatry 2004; 9: 981–983
   PubMed Web of Science ®Google Scholar
• Schwab SG, Hoefgen B, Hanses C, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 2005; 58: 446–450
   PubMed Web of Science ®Google Scholar
• Liu YL, Fann CS, Liu CM, et al. Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population. Psychiatr Genet 2006; 16: 39–41
   PubMed Web of Science ®Google Scholar
• Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636–45
   PubMed Web of Science ®Google Scholar
• Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996; 153: 321–330
   PubMed Web of Science ®Google Scholar
• Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992; 149: 898–903
   PubMed Web of Science ®Google Scholar
• Saykin AJ, Shtasel DL, Gur RE, et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 1994; 51: 124–131
   PubMed Web of Science ®Google Scholar
• Bilder RM, Goldman RS, Robinson D, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 2000; 157: 549–559
   PubMed Web of Science ®Google Scholar
• Lin CH, Yeh SH, Lu KT, Leu TH, Chang WC, Gean PW. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 2001; 31: 841–851
   PubMed Web of Science ®Google Scholar
• Mizuno M, Yamada K, Takei N, et al. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol Psychiatry 2003; 8: 217–224
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–1223
   PubMed Web of Science ®Google Scholar
• Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 2003; 29: 15–31
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders–administration booklet. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• American Psychiatric Association. diagnostic and statistical manual of mental disorders4th edn. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999; 14: 143–149
   PubMedGoogle Scholar
• Chen X, Sullivan PF. Single nucleotide polymorphism genotyping: biochemistry, protocol, cost, and throughput. Pharmacogenom J 2003; 3: 77–96
   PubMed Web of Science ®Google Scholar
• Keefe RS, Mohs RC, Bilder RM, et al. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull 2003; 29: 45–55
   PubMed Web of Science ®Google Scholar
• Keefe, RS, Bilder, RM, Harvey, PD, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006; 31:2033–2046.
   PubMed Web of Science ®Google Scholar
• Barrett, JC, Fry, B, Maller, J, Daly, MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263–265.
   PubMed Web of Science ®Google Scholar
• Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000; 405: 847–856
   PubMed Web of Science ®Google Scholar
• Sullivan PF, Eaves LJ, Kendler KS, Neale MC. Genetic case-control association studies in neuropsychiatry. Arch Gen Psychiatry 2001; 58: 1015–1024
   PubMed Web of Science ®Google Scholar
• Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 2000; 92: 1151–1158
   PubMedGoogle Scholar
• Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55: 997–1004
   PubMed Web of Science ®Google Scholar
• Freedman ML, Reich D, Penney KL, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 2004; 36: 388–393
   PubMed Web of Science ®Google Scholar
• Heiman GA, Hodge SE, Gorroochurn P, Zhang J, Greenberg DA. Effect of population stratification on case-control association studies. I @ Elevation in false positive rates and comparison to confounding risk ratios (a simulation study). Hum Hered 2004; 58: 30–39
   PubMed Web of Science ®Google Scholar
• Gorroochurn P, Hodge SE, Heiman G, Greenberg DA. Effect of population stratification on case-control association studies. II. False-positive rates and their limiting behavior as number of subpopulations increases. Hum Hered 2004; 58: 40–48
   PubMed Web of Science ®Google Scholar
• Shields AE, Fortun M, Hammonds EM, et al. The use of race variables in genetic studies of complex traits and the goal of reducing health disparities. Am Psychologist 2005; 60: 77–103
   PubMed Web of Science ®Google Scholar
• R Development Core Team. R: a language and environment for statistical computing. ViennaAustria: Foundation for Statistical Computing, 2004. Available from URL:, , http:// www.R-project.org.
   Google Scholar
• Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplolypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425–434
   PubMed Web of Science ®Google Scholar
• Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361(9360)865–872
   PubMed Web of Science ®Google Scholar
• Little J, Bradley L, Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002; 156: 300–310
   PubMed Web of Science ®Google Scholar
• Elvevag B, Goldberg TE. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 2000; 14: 1–21
   PubMed Web of Science ®Google Scholar